tBuO-C20-Glu(AEEA-AEEA-OSu)-OtBu
|
替爾泊肽側(cè)鏈NHS酯
|
1118767-17-1
|
NA
|
硫辛酸三聚體1
|
|
NA
|
地屈孕酮片氘代代謝產(chǎn)物
|
|
NA
|
對乙酰氨基酚氧化破壞雜質(zhì)3(RT=14.92min)
|
|
5-N-acetylneuraminic acid-5-bromo-3-indolyl-alpha-ketoside
|
N-乙?;?2-O-(5-溴-1H-吲哚-3-基)-a-神經(jīng)氨酸
|
64122-65-2
|
Sultamicillin EP Impurity F
|
舒他西林EP雜質(zhì)F
|
|
LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE)
|
左卡尼汀雜質(zhì)A混合物(E:Z=9:1)(Free Acid, E-isomer)
|
6538-82-5
|
Sultamicillin EP Impurity D
|
舒他西林EP雜質(zhì)D
|
|
Canagliflozin Peroxide Impurity
|
卡格列凈過氧化氫雜質(zhì)
|
2247196-28-5
|
Y-27632
|
4-[(1R)-1-氨基乙基]-N-(吡啶-4-基)環(huán)己烷-1-甲酰胺
|
146986-50-7
|
PENTANOIC ACID, 5-OXO-5-[[2-[3-OXO-3-[[6-[[3,4,6-TRI-O-ACETYL-2-(ACETYLAMINO)-2-DEOXY-Β-D-GALACTOPYRANOSYL]OXY]HEXYL]AMINO]PROPOXY]-1,1-BIS[[3-OXO-3-[[6-[[3,4,6
|
L96中間體; GalNAc中間體
|
1637413-82-1
|
2-Pyridinemethanol, α,α-bis[4-(sulfooxy)phenyl]-, sodium salt (1:2)
|
匹可硫酸鈉羥基化雜質(zhì)
|
2379878-05-2
|
Isocyclosporin A
|
異環(huán)孢素A(環(huán)孢素EP雜質(zhì)C)
|
59865-16-6
|
GAU;m7G(5')ppp(5')(2'OMeA)pU
|
帽類似物GAU
|
|
NA
|
多柔比星氧化雜質(zhì)
|
|
NA
|
卡絡(luò)磺鈉高溫降解雜質(zhì)1(卡絡(luò)磺鈉雜質(zhì)1)
|
|
NA
|
布美他尼美拉德雜質(zhì)
|
|
NA
|
尼可地爾三聚體雜質(zhì)
|
|
16-Hydroxyerythromycin
|
紅霉素EP雜質(zhì)A
|
82230-93-1
|
HO-PEG24-OH;PEG24
|
二十四甘醇;PEG24
|
2243942-52-9
|
N-DEMETHYL ERYTHROMYCIN A
|
紅霉素EP雜質(zhì)B
|
992-62-1
|
(2-hydroxytrimethylene)bis(trimethylammonium) dichloride
|
左卡尼汀雜質(zhì)
|
55636-09-4
|
4-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)butan-2-one
|
維生素A雜質(zhì)
|
20483-36-7
|
NA
|
阿扎胞苷一級水解產(chǎn)物異構(gòu)體2
|
|
NA
|
甘草酸乙酯雜質(zhì)2
|
|
NA
|
腎上腺素注射液RRT=0.16雜質(zhì)
|
|
tBuO-C18-Glu(AEEA-AEEA-OSu)-OtBu
|
司美格魯肽側(cè)鏈
|
1118767-15-9
|
CYCLOSPORINE RESOLUTION MIXTURE (25 MG)
|
環(huán)孢素U
|
108027-45-8
|
Hydrazinecarboxamide, 2-(1,2,3,6-tetrahydro-1-methyl-6-oxo-5H-indol-5-ylidene)-
|
卡絡(luò)磺鈉雜質(zhì)5
|
99069-59-7
|
Octanoic acid, 8,8'-dithiobis[6-mercapto- (6CI)
|
硫辛酸二聚體2
|
108841-56-1
|
3,3'-((2-(12-(benzyloxy)-12-oxododecanamido)-2-((2-carboxyethoxy)methyl)propane-1,3-diyl)bis(oxy))dipropionic acid
|
3,3'-((2-(12-(芐氧基)-12-氧代十二烷酰胺基)-2-((2-羧乙氧基)甲基)丙烷-1,3-二基)雙(氧基))二丙酸
|
2241043-42-3
|
5,8,11,14,17-Eicosapentaenoic acid, ethyl ester, (5Z,8Z,11Z,14Z,17E)-
|
EPA乙酯雜質(zhì)D
(5Z,8Z,11Z,14Z,17E-二十碳五烯酸乙酯)
|
125827-48-7
|
4-Epiminocycline
|
米諾環(huán)素差向異構(gòu)體
(米諾環(huán)素EP雜質(zhì)A)
|
43168-51-0
|
NA
|
9-氨基米諾環(huán)素差向異構(gòu)體
|
|
NA
|
地屈孕酮片代謝產(chǎn)物
|
|
NA
|
甘氨酸乳糖加合物
|
|
(S)-BTM
|
(2S)-2,3-二氫-2-苯基咪唑并[2,1-b]苯并噻唑
|
950194-37-3
|
(R)-De(carboxyMethyl) Cetirizine Ethanol Dihydrochloride
|
西替利嗪雜質(zhì)
|
728948-88-7
|
Levocarnitine iMpurity
|
左卡尼汀EP雜質(zhì)C
|
6490-20-6
|
ARCA;3'-O-Me-m7G(5')ppp(5')G
|
帽類似物ARCA
|
|
3'-OME-GAG;m7(3'OMeG)(5')ppp(5')(2'OMeA)pG
|
帽類似物3'-OME-GAG
|
|
β-D-Galactopyranoside, 2-(2-aminoethoxy)ethyl 2-(acetylamino)-2-deoxy-, 3,4,6-triacetate
|
|
1159409-21-8
|
NA
|
硫辛酸二聚體1
|
|
NA
|
西他沙星中間體RRT2.6雜質(zhì)
|
|
NA
|
對乙酰氨基酚氧化破壞雜質(zhì)1(RT9.33MIN)
|
|
NA
|
尼可地爾四聚體雜質(zhì)
|
|
3'-OME-GM6AG;m7(3'OMeG)(5')ppp(5')m6(2'OMeA)pG
|
帽類似物3'-OME-GM6AG
|
|
(2S,3S,4S,5R,6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
|
|
|
EPS
|
4,6-亞乙基-對硝基苯-Α-D-麥芽七糖苷
|
96597-16-9
|
GAG;m7G(5')ppp(5')(2'OMeA)pG
|
帽類似物GAG
|
|
WST-8
|
2-(2-甲氧基-4-硝基苯)-3-(4-硝基苯)-5-(2,4-二磺基苯)-2H-四氮唑單鈉鹽
|
193149-74-5
|
2-Propen-1-aminium, 3-carboxy-N,N,N-trimethyl-, chloride (1:1), (2Z)-
|
左卡尼汀雜質(zhì)A順式異構(gòu)體(Cl)
|
835638-57-8
|
Fmoc-L-Lys(Boc)-OSu
|
賴氨酸NHS
|
132307-50-7
|
(4aR,6R,7R,8R,8aS)-7-amino-2,2-dimethyl-6-(2-trimethylsilylethoxy)-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-8-ol
|
PTTG-4
|
122078-72-2
|
NA
|
阿扎胞苷二級水解產(chǎn)物異構(gòu)體1
|
|
NA
|
甘草酸乙酯雜質(zhì)3
|
|
NA
|
維生素B6中RT=12.239min雜質(zhì)
|
|
D-(+)-Camphoric acid
|
左卡尼汀EP雜質(zhì)B
|
124-83-4
|
10,14-Dioxa-2,6,18,22-tetraazatricosanedioic acid, 12-(13,13-dimethyl-5,11-dioxo-2,12-dioxa-6,10-diazatetradec-1-yl)-7,17-dioxo-12-[[(phenylmethoxy)carbonyl]amino]-, 1,23-bis(1,1-dimethylethyl) ester
|
3,3'-[[2-(CBZ-氨基)-2-[[3-[[3-(BOC-氨基)丙基]氨基]-3-氧代丙氧基]甲基]丙烷-1,3-二基]雙(氧基)]雙[N-[3-(BOC-氨基)丙基]丙酰胺
|
1162069-31-9
|
1,3-BIS(4-HYDROXYBUTYL)TETRAMETHYLDISILOXANE
|
1,3-雙(4-羥基丁基)四甲基二硅氧烷
|
5931-17-9
|
Pentanamide, N-(3-aminopropyl)-5-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-
|
(2R,3R,4R,5R,6R)-二乙酸[5-乙酰氨基-2-(乙酰氧基甲基)-6-[[5-[(3-氨基丙基)氨基]-5-氧代戊基]氧基]四氫-2H-吡喃-3,4-二基]酯
|
1637413-94-5
|
5,8,11,14,17-Eicosapentaenoic acid, ethyl ester, (5E,8Z,11Z,14Z,17Z)-
|
EPA乙酯雜質(zhì)F
(5E,8Z,11Z,14Z,17Z-二十碳五烯酸乙酯)
|
125827-50-1
|
NA
|
維生素A棕櫚酸酯雜質(zhì)1
|
|
NA
|
EPA乙酯雜質(zhì)E
(5Z,8Z,11Z,14E,17Z-二十碳五烯酸乙酯)
|
|
NA
|
蛋氨酸乳糖加合物
|
|
LANOSTEROL
|
羊毛甾醇
|
79-63-0
|
AMbroxol CycloiMine IMpurity
|
氨溴索雜質(zhì)
|
73220-00-5
|
CYCLOSPORIN D
|
環(huán)孢素EP雜質(zhì)G(環(huán)孢素D)
|
63775-96-2
|
H2N-PEG24-CH2CH2COOH
|
氨基二十四聚乙二醇丙酸
|
756526-07-4
|
CTP
|
CTP;5'-三磷酸胞苷
|
65-47-4
|
Acetic acid, 2-[2-[2-[2-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethoxy]ethoxy]-
|
|
1332358-25-4
|
β-D-Galactopyranoside, 2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl 2-(acetylamino)-2-deoxy-, 3,4,6-triacetate
|
|
1402209-74-8
|
(3R,4S,5S,6R,7R,9R,11R,12R,13R,14R)-4-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6 -dimethyl-oxan-2-yl]oxy-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-m ethyl-oxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexameth yl-1-oxacyclotetradecane-2,10-dione
|
紅霉素C
|
1675-02-1
|
NA
|
硫辛酸二聚體3
|
|
NA
|
西他沙星中間體RRT2.7雜質(zhì)
|
|
NA
|
對乙酰氨基酚氧化破壞雜質(zhì)2(RT=10.26min)
|
|
ANHYDROERYTHROMYCIN A
|
紅霉素EP雜質(zhì)D
|
23893-13-2
|
(E)-Sunitinib
|
舒尼替尼異構(gòu)體(E)
|
1691223-83-2
|
Carbazochrome Sodium Sulfonate Impurity 4
|
卡絡(luò)磺鈉雜質(zhì)4
|
|
1H-Indole-3-carboxylic acid, 2,3-dihydro-5,6-dihydroxy-
|
卡絡(luò)磺鈉雜質(zhì)2
|
25574-55-4
|
3,6-Diazabicyclo[3.1.1]heptane-6-carboxylic acid, 3-(5-bromo-2-pyrazinyl)-, 1,1-dimethylethyl ester
|
|
2493157-49-4
|
Methanesulfonic acid, 1,1,1-trifluoro-, 3-cyano-6-(3,6-dihydro-2H-pyran-4-yl)pyrazolo[1,5-a]pyridin-4-yl ester
|
|
2493157-88-1
|
Erythromycin E_x005f_x000b_Discontinued
|
紅霉素EP雜質(zhì)C
|
41451-91-6
|
NA
|
阿扎胞苷二級水解產(chǎn)物異構(gòu)體2
|
|
NA
|
西替利嗪聚乙二醇單酯
|
|
NA
|
布美他尼葡萄糖雜質(zhì)
|
|
NA
|
尼可地爾二聚體雜質(zhì)
|
|
Y-27632 DIHYDROCHLORIDE
|
Y-27632二鹽酸鹽
|
129830-38-2
|
(3-Carbamoylallyl)trimethylammonium
|
左卡尼汀EP雜質(zhì)D
|
857162-57-3
|
PUKNFWRLBQXPFL-FXRZFVDSSA-N
|
左卡尼汀雜質(zhì)A反式異構(gòu)體(Cl)
|
144205-67-4
|
Cyclosporin Impurity 25(Ciclosporin EP Impurity F)
|
環(huán)孢菌素雜質(zhì)12
|
437611-17-1
|
(R)-1-(3-(1-aminoethyl)-2-fluorophenyl)-1,1-difluoro-2-methylpropan-2-ol hydrochloride
|
左卡尼汀甲酯混合物(E:Z=9:1)
|
93621-78-4
|
Geclosporin
|
環(huán)孢素G
|
74436-00-3
|
NA
|
紅霉素雜質(zhì)O
|
|
NA
|
甘草酸乙酯雜質(zhì)1
|
|
NA
|
舒他西林RT=32.075min雜質(zhì)
|
|
N-(ForMyl aMidino)-N-β-D-ribofuranosylurea
|
阿扎胞苷一級水解產(chǎn)物異構(gòu)體1
|
65126-88-7
|
3,3'-((2-(((Benzyloxy)carbonyl)amino)-2-((2-carboxyethoxy)methyl)propane-1,3-diyl)bis(oxy))dipropionic acid
|
3,3'-[[2-(CBZ-氨基)-2-[(2-羧基乙氧基)甲基]丙烷-1,3-二基]雙(氧基)]二丙酸
|
200133-16-0
|
Azacitidine Impurity 3
|
阿扎胞苷α異構(gòu)體
|
157771-77-2
|
mCAP;m7G(5')ppp(5')G
|
帽類似物mCAP
|
9001-78-9
|